Omentin-1 plasma levels and omentin-1 expression are decreased in psoriatic lesions of psoriasis patients

Archives of Dermatological Research

Volumn 307, Issue 5, 2015, Pages 455-459

  Zhang, C ^a   Zhu, K J ^b   Liu, J L ^a   Xu, G X ^a   Liu, W ^a   Jiang, F X ^a   Zheng, H F ^c   Quan, C ^d  

^a ANHUI PROVINCIAL HOSPITAL   (China)

^b GUANGDONG MEDICAL UNIVERSITY   (China)

^c MCGILL UNIVERSITY   (Canada)

^d XUZHOU MEDICAL UNIVERSITY   (China)

Author keywords

Adipokines; Body mass index; Omentin; Psoriasis

Indexed keywords

GENOMIC DNA; OMENTIN 1; PROTEIN; UNCLASSIFIED DRUG; ADIPOCYTOKINE; CYTOKINE; GLYCOSYLPHOSPHATIDYLINOSITOL ANCHORED PROTEIN; ITLN1 PROTEIN, HUMAN; LECTIN;

ADULT; ARTICLE; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE DURATION; DNA EXTRACTION; DNA POLYMORPHISM; ENDOTHELIUM CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; EPIDERMIS; FAMILY HISTORY; FEMALE; GENETIC VARIABILITY; GENOTYPE; HAIR FOLLICLE; HOMOZYGOSITY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; ONSET AGE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PSORIASIS; PSORIASIS AREA AND SEVERITY INDEX; SEBACEOUS GLAND; SINGLE NUCLEOTIDE POLYMORPHISM; SKIN BIOPSY; SWEAT GLAND; YOUNG ADULT; BIOPSY; BLOOD; BODY MASS; GENE EXPRESSION REGULATION; GENETICS; GENOTYPING TECHNIQUE; METABOLISM; PHYSIOLOGY; SKIN;

ADIPOKINES; ADULT; BIOPSY; BODY MASS INDEX; CYTOKINES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE EXPRESSION REGULATION; GENOTYPING TECHNIQUES; GPI-LINKED PROTEINS; HUMANS; LECTINS; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; PSORIASIS; SKIN;

EID: 84931559978     PISSN: 03403696     EISSN: 1432069X     Source Type: Journal    
DOI: 10.1007/s00403-015-1549-z     Document Type: Article

References (21)

1. (2000) Obesity: preventing and managing the global epidemic. Report of a WHO consultation. World Health Organ Tech Rep Ser.; 894:i–xii, 1–253
2. Alsufyani MA, Golant AK, Lebwohl M (2010) Psoriasis and the metabolic syndrome. Dermatol Ther 23(2):137–143
3. Auguet T, Quintero Y, Riesco D et al (2011) New adipokines vaspin and omentin. Circulating levels and gene expression in adipose tissue from morbidly obese women. BMC Med Genet 12:60
4. Cargill M, Schrodi SJ, Chang M et al (2007) A large-scale genetic association study confirms IL12B and leads to the identification of IL23R as psoriasis-risk genes. Am J Hum Genet 80(2):273–290
5. de Souza Batista CM, Yang RZ, Lee MJ et al (2007) Omentin plasma levels and gene expression are decreased in obesity. Diabetes 56(6):1655–1661
6. Gerkowicz A, Pietrzak A, Szepietowski JC et al (2012) Biochemical markers of psoriasis as a metabolic disease. Folia Histochem Cytobiol 50(2):155–170
7. Ismail SA, Mohamed SA (2012) Serum levels of visfatin and omentin-1 in patients with psoriasis and their relation to disease severity. Br J Dermatol 167(2):436–439
8. Komiya T, Tanigawa Y, Hirohashi S (1998) Cloning of the novel gene intelectin, which is expressed in intestinal paneth cells in mice. Biochem Biophys Res Commun 251(3):759–762
9. Langley RG, Ellis CN (2004) Evaluating psoriasis with Psoriasis Area and Severity Index, Psoriasis Global Assessment, and Lattice System Physician’s Global Assessment. J Am Acad Dermatol 51(4):563–569
10. Lee JK, Schnee J, Pang M et al (2001) Human homologs of the Xenopus oocyte cortical granule lectin XL35. Glycobiology 11(1):65–73
11. Schaffler A, Neumeier M, Herfarth H et al (2005) Genomic structure of human omentin, a new adipocytokine expressed in omental adipose tissue. Biochim Biophys Acta 1732(1–3):96–102
12. Schaffler A, Zeitoun M, Wobser H et al (2007) Frequency and significance of the novel single nucleotide missense polymorphism Val109Asp in the human gene encoding omentin in Caucasian patients with type 2 diabetes mellitus or chronic inflammatory bowel diseases. Cardiovasc Diabetol 6:3
13. Schön MP, Boehncke WH (2005) Psoriasis. N Engl J Med 352(18):1899–1912
14. Splichal Z, Bienertova-Vasku J, Novak J et al (2015) The common polymorphism Val109Asp in the omentin gene is associated with daily energy intake in the Central-European population. Nutr Neurosci 18(1):41–48
15. Takahashi H, Tsuji H, Honma M, Ishida-Yamamoto A, Iizuka H et al (2013) Increased plasma resistin and decreased omentin levels in Japanese patients with psoriasis. Arch Dermatol Res 305(2):113–116
16. Turan H, Yaykasli KO, Soguktas H et al (2013) Omentin serum levels and omentin gene Val109Asp polymorphism in patients with psoriasis. Int J Dermatol 53(5):601–605
17. Wang C (2014) Obesity, inflammation, and lung injury (OILI): the good. Mediat Inflamm 2014:978463
18. Wang Y, Lam KS, Kraegen EW et al (2007) Lipocalin-2 is an inflammatory marker closely associated with obesity, insulin resistance, and hyperglycemia in humans. Clin Chem 53(1):34–41
19. Yang RZ, Lee MJ, Hu H et al (2006) Identification of omentin as a novel depot-specific adipokine in human adipose tissue: possible role in modulating insulin action. Am J Physiol Endocrinol Metab 290(6):E1253–E1261
20. Yoruk U, Yaykasli KO, Ozhan H et al (2014) Association of omentin Val109Asp polymorphism with coronary artery disease. Anadolu Kardiyol Derg 14(6):511–514
21. Zeggini E, Scott LJ, Saxena R et al (2008) Meta-analysis of genome-wide association data and large-scale replication identifies additional susceptibility loci for type 2 diabetes. Nat Genet 40(5):638–645